Psychiatry and Neurology, Neurology · Louisville, KY
NPI
1831358506
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3991 Dutchmans Ln, Suite 310
Louisville, KY, 40207
Phone (502) 899-6782
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
363 services
Medicare patients, 2024
218
Average age 64
Drug cost, 2024
$6.8M
3,505 prescriptions
Company payments, 2025
$1,031
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geeta A Ganesh was code 99213 (office e&m - established), 220 times for 171 patients. In total Geeta A Ganesh billed 363 services in 7 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 220 | 171 | $41.39 | $9,106 |
| 99214 Office E&M - Established | Facility | 122 | 118 | $69.10 | $8,430 |
By year: 2022 $23K for 372 services; 2023 $21K for 397 services; 2024 $19K for 363 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 16 | 15 | $2.97 | $47.58 |
Medicare prescription drug claims, 2024
In 2024, the drug Geeta A Ganesh prescribed most often to Medicare patients was Gabapentin, with 421 prescriptions and refills. In total Geeta A Ganesh wrote 3,505 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 421 | 676 | 109 | $7,129 |
| Baclofen Generic | 260 | 518 | 66 | $5,388 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 183 | 183 | 28 | $4,241 |
| Dalfampridine Er Dalfampridine | 181 | 214 | 27 | $68K |
| Teriflunomide Generic | 133 | 178 | 19 | $128K |
| Kesimpta Pen Ofatumumab | 125 | 154 | 17 | $1.3M |
| Tizanidine Hcl Generic | 111 | 197 | 38 | $1,302 |
| Dimethyl Fumarate Generic | 104 | 106 | 13 | $55K |
| Modafinil Generic | 89 | 115 | 19 | $8,707 |
| Duloxetine Hcl Generic | 85 | 163 | 19 | $1,412 |
| Mayzent Siponimod | 78 | 109 | Under 11 | $929K |
| Glatiramer Acetate Generic | 76 | 79 | 12 | $196K |
| Pregabalin Generic | 73 | 118 | 19 | $3,375 |
| Oxcarbazepine Generic | 69 | 132 | 17 | $3,314 |
| Amantadine Amantadine Hcl | 68 | 100 | 19 | $4,400 |
Brand drugs: 608 claims; generic drugs: 2,897 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Geeta A Ganesh $1,031 ($1,031 in general payments such as food, travel and fees) from 9 companies. The largest payer was Vanda Pharmaceuticals Inc. with $786.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.